View Alert
Originator: DHSC & NHS England and Improvement: Supply disruption alert

Issue date: 25-Oct-2019 11:08:59

Action by recipients:
  • Care Trusts
  • Mental Health Trusts
  • Specialists Trusts
  • NHS Regional Offices
  • Learning Disabilities Trusts
  • Mental Health & Social Care Trusts
  • Ambulance Trusts
  • Mental Health & Learning Disabilities
  • Acute Trusts
  • Community Trusts

Information to recipients:
  • MHRA (Medicines) Drug Alerts (Various Recipients)
  • Independent Healthcare Providers (registered with CAS)
  • Clinical Commissioning Groups
  • Social Care Providers (registered with CAS)
  • MHRA (Medicines) Drug Alerts - Non-NHS Recipients
  • GP - Locum
  • GP Practices
  • DHSC Supply Disruption - Medicines

Action category: Action

Title: Opicapone 50mg capsules: supply disruption

Broadcast content: Ongentys (opicapone) 50mg capsules, manufactured by Bial Pharmaceuticals will be out of stock from mid-November 2019 to mid-January 2020.

This alert provides advice on the management of patients currently using this medicine.


Additional information: GP Practices: please share this alert within your practice to assist the management of patients using this medicine.
NHS Regional Offices: please cascade this alert to community pharmacy.


Alert reference: SDA/2019/007

Action underway deadline: 01-Nov-2019

Action complete deadline: 31-Jan-2020

Attachments:

Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency